With new cases of COVID-19 still in the tens of thousands per day across the globe, scientists are working hard…
The long acting monoclonal antibody nirsevimab (marketed as Beyfortus) reduced respiratory syncytial virus associated hospital admissions in infants by 83%,…
Credit: Pixabay/CC0 Public Domain Researchers have identified a wide range of risk factors for young-onset dementia. The findings challenge the…
This website uses cookies.